ImmunityBio Inc. Common Stock vs SK Telecom Co. Ltd. Common Stock — how do they compare? ImmunityBio Inc. Common Stock trades at $10.01 (market cap $10.33B), while SK Telecom Co. Ltd. Common Stock trades at $34.15 (market cap $13.90B). The key difference: SK Telecom Co. Ltd. Common Stock is the larger of the two by market cap, and SK Telecom Co. Ltd. Common Stock pays a 2.73% dividend while ImmunityBio Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 0 Days and SK Telecom Co. Ltd. Common Stock for 0 Days on average.
| IBRX | SKM | |
|---|---|---|
Market Cap | $10.33B | $13.90B |
Volume | 11,745,198 | 1,045,075 |
Sector | Health | Media |
52-Week High | $11.55 | $46.00 |
52-Week Low | $1.98 | $19.68 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $10.79B | $19.95B |
Dividend Yield | — | 2.73% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →SK Telecom is a South Korean telecommunications company providing mobile, broadband, and digital services. It also develops services in areas such as AI, cloud, and data centers.
Read more on SKM →